rpmi 1640 media (ATCC)
Structured Review
Rpmi 1640 Media, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4458 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/media+rpmi+1640/Jurkat%2C+Clone+E6-1/us12655229-655-15-11
Average 99 stars, based on 4458 article reviews
Images
Related Articles
Cell Culture:Article Title: The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy Article Snippet: .. Cells were cultured in appropriate media (RPMI-1640, Article Title: Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia Article Snippet: .. Cells were cultured in appropriate media (RPMI-1640, Article Title: Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Article Snippet: Purpose Despite great advances that have been made in the understanding of the molecular complexity of acute myeloid leukemia (AML), very little has been translated into new therapies.. Here, we set out to investigate the impact of cytoskeleton regulatory genes on clinical outcomes and their potential as therapeutic targets in AML.. Methods Gene expression and clinical data were retrieved from The Cancer Genome Atlas (TCGA) AML study and used for survival and functional genomics analyses. Article Title: Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms Article Snippet: SUP-B15 was kindly provided by Dr. Lucas Eduardo Botelho de Souza (National Institute of Science and Technology in Stem Cells and Cell Therapy, Ribeirão Preto, São Paulo, Brazil). .. The cells were cultured in an appropriate media (RPMI-1640, Article Title: Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia. Article Snippet: Acute myeloid leukemia (AML) often develops resistance to the BCL2 inhibitor venetoclax through metabolic reprogramming.. This study established acquired venetoclax-resistant AML models (MV4-11VR and MOLM13VR) to explore resistance mechanisms and therapeutic strategies.. Cell viability and apoptosis assays revealed robust acquired resistance to venetoclax upon intermittent drug exposure. Article Title: The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Article Snippet: .. Cells were cultured in appropriate media (RPMI-1640, Suspension:Article Title: Enabling In Vivo Photocatalytic Activation of Rapid Bioorthogonal Chemistry by Repurposing Silicon-Rhodamine Fluorophores as Cytocompatible Far-Red Photocatalysts. Article Snippet: .. The cell suspension was centrifuged at 450 rpm for 5 min and a total of 450k cells were resuspended into media (193 μL, RPMI-1640, ATCC) Concentration Assay:Article Title: Enabling In Vivo Photocatalytic Activation of Rapid Bioorthogonal Chemistry by Repurposing Silicon-Rhodamine Fluorophores as Cytocompatible Far-Red Photocatalysts. Article Snippet: .. The cell suspension was centrifuged at 450 rpm for 5 min and a total of 450k cells were resuspended into media (193 μL, RPMI-1640, ATCC) |
